Over the past two decades, thoracic oncology has undergone a profound transformation, moving from limited chemotherapy ...
Dr. Girindra Raval sat down for an interview with CURE to discuss what patients with EGFR-mutated lung cancer should know about their treatment options, highlighting the latest advancements in ...
Pulmonary malignancy is one of the most frequent and fatal cancers in older patients. Studies have shown that lung cancer patients have a high incidence of lower respiratory tract infections. This is ...
What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...
CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...
Alpha-9 Oncology, a clinical-stage radiotherapeutic company developing targeted cancer therapies, today announced the initiation of dosing in a Phase 1 study evaluating A9-3408, a novel ...
Efficacy and Safety of Sintilimab Plus Anlotinib for PD-L1–Positive Recurrent or Metastatic Cervical Cancer: A Multicenter, Single-Arm, Prospective Phase II Trial Radiation therapy (RT) is a commonly ...
Cancer treatment has come a long way since the days of just chemotherapy. Today, many people are hearing about targeted ...
NEW YORK, Nov. 25, 2025 /PRNewswire/ -- Nucs AI, the leader in AI-based radiology solutions, today announced the launch of TrackPSMA, a breakthrough tool that gives physicians a faster, quantitative ...
Patients with cancer who forego surgery have higher suicide incidence than those who undergo treatment, a study finds. Patients with cancer who did not undergo surgery faced a significantly higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback